The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
// STATE LEGISLATION TRACKER

New Mexico SB 193: WEIGHT LOSS DRUGS INSURANCE COVERAGE

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed
State
New Mexico
Bill
SB 193
Session
2026
Filed
2025-01-29
Read the bill
OpenStates →
Last reviewed
2026-10-02

Plain-English Summary

New Mexico SB193 is a water infrastructure funding bill, not a health care or pharmacy bill. Based on the title, subjects, and available bill information, it does not affect compounded peptides, prescribing, telehealth, clinician scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

  • No apparent impact on peptide access or prescribing
  • Does not appear to change pharmacy compounding rules
  • Does not address telehealth or clinician scope
  • Focuses on acequia and community ditch infrastructure funding

What to Watch For

i
Note No peptide-specific provisions are apparent from the bill title, subjects, or summary.
i
Note The bill is about water and irrigation funding, so peptide users and clinicians likely do not need to act.
i
Note Status information differs from the prompt: state records show it was signed by the governor on March 9, 2026.

Where the Bill Stands

The bill passed both chambers and was signed by the governor on March 9, 2026, becoming Chapter 56.
· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws